High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: A predictive molecular marker of metachronous liver and lung metastases

Clinical Cancer Research

Volumn 10, Issue 21, 2004, Pages 7318-7328

  Kato, Hirotaka ^a   Semba, Shuho ^a   Miskad, Upik A ^a   Seo, Yasushi ^a   Kasuga, Masato ^a   Yokozaki, Hiroshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; PHOSPHATASE OF REGENERATING LIVER 3; PROTEIN TYROSINE PHOSPHATASE; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; PROTEIN-TYROSINE-PHOSPHATASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 8444228839     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0485     Document Type: Article

References (26)

1. Shike M, Winawer SJ, Greenwald PH, Bloch A, Hill MJ, Swaroop SV. Primary prevention of colorectal cancer. The WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ 1990;68:377-85.
2. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
3. Saha S, Bardelli A, Buckhaults P, et al. A phosphatase associated with metastasis of colorectal cancer. Science (Wash DC) 2001;294:1343-6.
4. Zhang ZY, Zhou B, Xie L. Modulation of protein kinase signaling by protein phosphatases and inhibitor. Pharmacol Ther 2002;93:307-17.
5. Cates CA, Michael RL, Stayrook KR, et al. Prenylation of oncogenic human PTP (CAAX) protein tyrosine phosphatases. Cancer Lett 1996;110:49-55.
6. Zeng Q, Hong W, Tan YH. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem Biophys Res Commun 1998;244:421-7.
7. Zeng Q, Si X, Horstmann H, Xu Y, Hong W, Pallen CJ. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J Biol Chem 2000;275:21444-52.
8. Diamond RH, Cressman DE, Laz TM, Abrams CS, Taub R. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol 1994;14:3752-62.
9. Matter WF, Estridge T, Zhang C, et al. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem Biophys Res Commun 2001;83:1061-8.
10. Mohn KL, Laz TM, Hsu JC, Melby AE, Bravo R, Taub R. The immediate-early growth response in regenerating liver and insulin-stimulated H35 cells comparison with serum stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol Cell Biol 1991;11:381-90.
11. Montagna M, Serova O, Sylla BS, Feunteun J, Lenior GM. A 100-kb physical and transcriptional map around the EDH17B2 gene: identification of three novel genes and a pseudogene of a human homologue of the rat PRL-1 tyrosine phosphatase. Hum Genet 1995;96:532-8.
12. Zeng Q, Dong J, Guo K, et al. PRL-3 and PRL-1 promote cell migration, invasion and metastasis. Cancer Res 2003;63:2716-22.
13. Japanese Society for Cancer of Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 6th ed. Tokyo: Kanehara Public Co; 1998.
14. Sobin LH, Wittekind CH. UICC TNM Classification of malignant tumors. 5th ed. New York: John Wiley & Sons, Inc; 1997.
15. Carol AS, Michelle H, Michael JdV, Robert HS, Bryan RGW. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003;5:834-9.
16. Semba S, Itoh N, Ito M, Harada M, Yamakawa M. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenylchrmone (LY294002), a specific inhibitor of phosphatidyl inositol 3′-kinase in human colon cancer cells. Clin Cancer Res 2002;8:1957-63.
17. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988;85:2444-8.
18. Park CS, Manahan LJ, Brigati DJ. Automated molecular pathology: one hour in situ DNA hybridization. J Histotechnol 1991;14:219-29.
19. Caruthers MH, Becaucage SL, Efcavitch JW, et al. Chemical synthesis and biological studies on mutated gene-control region. Cold Spring Harbor Symp Quant Biol 1982;47:411-8.
20. Reed JA, Manahan LJ, Park CS, Brigati DJ. Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992;13:434-43.
21. Zhao Z, Lee CC, Monckton DG, et al. Characterization and genomic mapping of genes and pseudogenes of a new human protein tyrosine phosphatase. Genomics 1996;35:172-81.
22. Seabra MC. Review: Membrane association and targeting of prenylated Ras-like GTPases. Cell Signalling 1998;10:167-72.
23. Si X, Zeng Q, Ng CH, Hong W, Pallen CJ. Interaction of farnesylated PRL-2, a protein-tyrosine phosphatase, with the beta-submit of geranylgeranyltransferase II. J Biol Chem 2001;276:32875-82.
24. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
25. Bardelli A, Saha S, Sager JA, et al. PRL-3 expression in metastatic cancers. Clin Cancer Res 2003;9:5607-15.
26. Sadahiro S, Suzuki T, Ishikawa K, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepato-Gastroenterology 2003;50:1362-6.